Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of MYL2 mRNA | decreases expression | 18180321
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of MYL2 mRNA | increases expression | 18180321
|
C086539 |
BQ 788 |
BQ 788 inhibits the reaction [AGT protein results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 15007106
|
C086539 |
BQ 788 |
BQ 788 inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 15007106
|
D002104 |
Cadmium |
Cadmium results in decreased expression of MYL2 mRNA | decreases expression | 17327700
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of MYL2 mRNA | decreases expression | 17327700
|
C072247 |
cyclo(Trp-Asp-Pro-Val-Leu) |
cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [AGT protein results in increased expression of MYL2 protein] | decreases reaction|increases expression | 15007106
|
C072247 |
cyclo(Trp-Asp-Pro-Val-Leu) |
cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 15007106
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of MYL2 mRNA | increases expression | 18042831
|
D000431 |
Ethanol |
Ethanol results in decreased expression of MYL2 mRNA | decreases expression | 17920746
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYL2 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of MYL2 mRNA | increases expression | 18035473
|
C056599 |
icariin |
icariin results in increased expression of MYL2 mRNA | increases expression | 16490167 15780198
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of MYL2 mRNA | increases expression | 12634122
|
D010126 |
Ozone |
Ozone results in decreased expression of MYL2 mRNA | decreases expression | 12763052
|
C041786 |
palm oil |
palm oil results in increased expression of MYL2 mRNA | increases expression | 18042831
|
D010656 |
Phenylephrine |
ADM protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 11470465
|
D010656 |
Phenylephrine |
BQ 788 inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 15007106
|
D010656 |
Phenylephrine |
cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 15007106
|
D010656 |
Phenylephrine |
MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA] | decreases reaction|increases expression | 11513749
|
D010656 |
Phenylephrine |
MYOCD protein promotes the reaction [Phenylephrine results in increased expression of MYL2 protein] | increases expression|increases reaction | 14676212
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of MYL2 mRNA | increases expression | 11470465
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of MYL2 protein | increases phosphorylation | 18202317
|
D010656 |
Phenylephrine |
Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MYL2 mRNA | increases expression | 17951219
|
C059514 |
resveratrol |
resveratrol results in decreased expression of MYL2 mRNA | decreases expression | 17588540
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MYL2 mRNA | increases expression | 15716485
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYL2 mRNA | affects cotreatment|increases expression | 17942748
|
D014544 |
Uridine Triphosphate |
Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212
|
D014544 |
Uridine Triphosphate |
Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein] | decreases reaction|increases expression | 14676212
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
8.35 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.35 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ethanol |
4.46 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.81 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.08 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.80 | 14692618 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.29 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.78 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.78 | 16835633 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.29 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
icariin |
6.83 | 19858766 19782061 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
6.83 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.83 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.91 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.78 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.97 | 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.07 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.78 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.78 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.27 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.27 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.55 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.62 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
6.95 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.95 | 17967414 16873680 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001847 |
Bone Diseases |
|
icariin |
6.37 | 18295595 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.73 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.82 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.51 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
icariin |
10.63 | 19303870 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
10.63 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.96 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.96 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.96 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.64 | 18315731 16777450 15516495 18417511 19059883 17626835 14754758 |
MESH:D002056 |
Burns |
|
Ethanol |
4.61 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.70 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.76 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
3.37 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
3.37 | 16227395 19321006 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.95 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.56 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.70 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
11.35 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
11.35 | 17124262 11754973 15728586 11179087 17287366 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
11.35 | 18850075 18670907 16120746 |
OMIM:608758 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10 |
marker/mechanism |
|
| |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.44 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
7.35 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
7.35 | 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.63 | 11677210 17681005 17333356 16105132 15861022 16919318 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.63 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.56 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.89 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.89 | 12621046 8697196 16354765 15668235 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.09 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.45 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.72 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.62 | 15451039 15513904 19302082 10194807 15451040 11873399 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.62 | 15322242 10048152 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.73 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.92 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
3.89 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.89 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.73 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.42 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.20 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.20 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.20 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.99 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.99 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.81 | 17923197 |
MESH:D007172 |
Erectile Dysfunction |
|
icariin |
5.39 | 16281085 15329286 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.74 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
18.45 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
18.45 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.45 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.45 | 20131406 19236843 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.64 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.26 | 16946407 15451040 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.49 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.49 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.66 | 15046732 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.31 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.51 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.13 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.13 | 12621046 16120746 15340226 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.14 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 16354765 15340226 18606429 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.68 | 18783367 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.08 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
9.08 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.15 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.15 | 16873680 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
5.25 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.25 | 18670907 18850075 |
MESH:D006976 |
Hypertension, Pulmonary |
|
cyclo(Trp-Asp-Pro-Val-Leu) |
5.16 | 16327149 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.51 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.26 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.77 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.61 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.46 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.80 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.80 | 17296493 |
MESH:D007249 |
Inflammation |
|
resveratrol |
11.80 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.80 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.52 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.17 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.17 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.17 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.98 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.98 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
6.60 | 16226777 16322080 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
6.60 | 16962696 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
10.12 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
icariin |
10.12 | 19782061 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.55 | 16087638 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.78 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.76 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.76 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
5.06 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.43 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.43 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.43 | 12878042 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.61 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.30 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.30 | 19812893 19321006 19073162 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.30 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.08 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.35 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.81 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.37 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.37 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.26 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.83 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.21 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.08 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.36 | 17992120 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
10.04 | 18411066 15451040 |
MESH:D008569 |
Memory Disorders |
|
icariin |
10.04 | 19782061 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.34 | 17112576 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.08 | 10496685 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.85 | 17671175 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.43 | 17164350 14749477 16267019 17049120 17935668 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.83 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.68 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.68 | 17188708 17015251 16525036 16317513 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.89 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.89 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.91 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.72 | 17322642 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.93 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.96 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.45 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.45 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.77 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.36 | 17929310 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.40 | 16723640 17217161 18457598 21332399 18674790 20518802 11836018 20132043 19632207 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.40 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
icariin |
4.59 | 19747809 18236786 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.21 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.95 | 11985600 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.95 | 12384795 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.35 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.09 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.36 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.09 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
16.09 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.09 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.17 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.77 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.77 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.77 | 17636462 16731767 17804756 17675339 15767336 17718901 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 16919318 15861022 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.75 | 10548101 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.55 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.50 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.50 | 17058453 16314181 15827377 17520802 16317513 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012640 |
Seizures |
|
Ethanol |
3.14 | 9754883 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.67 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.65 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.65 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.91 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.49 | 9562338 17918041 17189318 11906479 16755016 9211565 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.44 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.95 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.21 | 9754883 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.17 | 16227395 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.06 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.98 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.36 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.36 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.26 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.70 | 16723640 |